A-shares closed · 港股休市 Quotes 行情 · 25 Sep 17:19 CST
26 Sep 2026 · 00:42 CST Terminal Access 终端入口 →

Gao Xuemin 高学敏

Male 男 · 88 years old · Bachelor's 本科 · Two seats at two companies · Identity confirmed by person code

Companies 任职公司

Company 公司Industry 行业Role 职务Since 起始Grade 评级
Qinghai Spring *ST春天Food Processing 食品加工Independent Director 独立董事30 May 2023E 25
Fangsheng Pharmaceutical 方盛制药Traditional Chinese Medicine 中药ⅡIndependent Director 独立董事20 Jan 2025C 66

Biography 简历

高学敏,本科学历,历任国家药典委员会七、八、九、十届委员、十一、十二届顾问委员,并任第八届药典会中医专业委员会主委,中华中医药学会中药基础理论分会主委、名誉主委,国家卫生健康委儿童用药专家委员会主委、中国中药协会药物临床评价研究专业委员会主委,药监局、新药、中药品种保护、保健食品、麻醉药品评审委员会委员、国家基本药物目录专家委员会委员、中国药物滥用防治协会理事,《基本医疗保险药品目录(中药部分)》专家咨询小组成员,国家科委国家秘密技术级专家审查专家组专家;精华制药集团股份有限公司独立董事。现任卫健委儿童用药专委会名誉主委,北京中医药大学资深教授、博士生导师,享受国务院政府特殊津贴,中医药管理局重点学科临床中药学学术带头人,青海春天药用资源科技股份有限公司独立董事、公司独立董事。

English Translation 英文译文 · Organisation Names in Chinese 机构名称保留中文Gao Xuemin, with a bachelor's education, has served as a member of the 7th, 8th, 9th, and 10th terms of the National Pharmacopoeia Commission, and as an advisory member of the 11th and 12th terms. He was also the chief of the Traditional Chinese Medicine Professional Committee of the 8th Pharmacopoeia Meeting, the chief and honorary chief of the Basic Theory of Chinese Medicine Professional Committee of 中华中医药学会, the chief of the Expert Committee on Children's Medication of the National Health Commission, the chief of the Drug Clinical Evaluation Research Professional Committee of 中国中药协会, a member of the Drug Supervision Bureau, the New Drugs, the Protection of Chinese Medicine Varieties, Health Food, and the Anesthetic Drugs Review Committee, a member of the National Basic Drug Catalog Expert Committee, a councilor of 中国药物滥用防治协会, a member of the Expert Advisory Group on the 'Basic Medical Insurance Drug Catalog (Chinese Medicine Part)', and an expert of the National Science Commission's National Secret Technology Level Expert Review Group. Independent Director of 精华制药集团股份有限公司 (Jinghua Pharmaceutical Group). Currently serves as the honorary chief of the Expert Committee on Children's Medication of the National Health Commission, a senior professor and doctoral supervisor at 北京中医药大学, enjoys special government allowance from the State Council, the academic leader of the key discipline of clinical Chinese medicine at 中医药管理局, and an independent director of 青海春天药用资源科技股份有限公司 (Qinghai Spring) and an independent director of the company.